Imagine a cancer patient waiting for a breakthrough therapy that could save their life. The drug exists it is a biologic, a cutting-edge medicine derived from living cells but the price is so high that it remains out of reach. Now imagine a cheaper alternative, a biosimilar, offering the same clinical benefits at a fraction… Continue reading Patents vs. Patients: Navigating Barriers in India’s Biopharma Future
Patents vs. Patients: Navigating Barriers in India’s Biopharma Future